Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Virpax Pharmaceuticals Inc
VRPX
Healthcare
Virpax Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company. The Company is focused on developing novel and proprietary drug delivery systems across various pain indication. Its drug-delivery systems and drug-releasing technologies being developed are focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system (CNS...
) disorders to enhance patients’ quality of life. Its portfolio consists of multiple preclinical stage product candidates: Epoladerm, Probudur, Envelta, AnQlar and NobrXiol. Probudur is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain. Envelta is an intranasal molecular envelope enkephalin formulation being developed to manage acute and chronic pain, including pain associated with cancer. The NobrXiol is being developed for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management of rare pediatric epilepsy.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:VRPX)
New Post
View:
Posts & Comments
Threaded Posts
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 22, 2024 8:49am
VRPX...back to back NR's & vol & Price action
Me personally....wouldn't touch this with a 10 Ft pole U do u currently trading at ~ $0.93 on over 33 mil shs
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 5:01am
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX): Navigating the C
https://beyondspx.com/2024/08/02/virpax-pharmaceuticals-inc-nasdaqvrpx-navigating-the-challenges-of-a-preclinical-stage-pharmaceutical-company/
Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents
posted Dec 03, 2024 9:00am by
Revive Therapeutics Ltd
-
|
Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more
(269)
•••
whytestocks
X
Post by
whytestocks
on Jul 09, 2024 3:02pm
Spotting Penny Stocks With Breakout Potential, 3 Tips
NEWS: $VRPX Spotting Penny Stocks With Breakout Potential, 3 Tips2024-07-09 06:01:00 ET 3 Tips for Spotting Penny Stocks That Could Breakout Spotting penny stocks with breakout potential requires a
...more
(269)
•••
whytestocks
X
Post by
whytestocks
on Jul 08, 2024 1:30pm
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are O
Breaking News: $VRPX Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session | BenzingaShares of Arhaus, Inc. (NASDAQ:ARHS) fell sharply during
...more
(269)
•••
whytestocks
X
Post by
whytestocks
on Feb 27, 2024 6:45pm
Virpax Pharmaceuticals Announces Reverse Stock Split to Rega
Just In: $VRPX Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid PriceVirpax ® Pharmaceuticals, Inc. (“Virpax” or
...more
(59)
•••
Nibinator
X
Post by
Nibinator
on Dec 14, 2023 4:35pm
Buy buy buy
Looking fine after market buy at .27
(0)
•••
LinethRamirez
X
Post by
LinethRamirez
on Aug 23, 2021 12:35am
📢📢📣📣📺FSD Pharma Inc CEO Anthony Durkacz (Nasdaq: HUGE)
(0)
•••
LannieMich23
X
Post by
LannieMich23
on Aug 19, 2021 7:19am
FSD Pharma Inc CEO Anthony Durkacz (Nasdaq: HUGE)(CSE:HUGE)
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 26, 2021 1:02pm
VRPX....halted x's 3 & NR....on watch
Cheers !
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 07, 2021 1:16pm
BSQR ..... I'm thinking there will be a P.O announcement
The volume over the past week has been astounding Here is the EDGAR link : EDGAR Entity Landing Page (sec.gov)
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 07, 2021 12:23pm
RE:VRPX ....in some here
Flat trdaed a small position..... It showed some promise but failed to deliver No position now.....volume has declined Moving on to VIVE....maybe
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 07, 2021 12:07pm
VRPX ..... watching for a break of $4.43
if it does ....it's a quick jaunt to $4.63 Just my take. Cheers !
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 07, 2021 11:53am
VRPX ....in some here
$5.28
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 07, 2021 11:27am
VRPX .... On watch
Now in PB mode ~$6
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec